ALL NEWS

Newborn Solutions participates in the EU-India InnoCenter “Explore and Validate” programme, an extensive 10 week schedule that will enable us to discover and understand the Indian market, and tap into opportunities that will arise from our taking part.

Newborn Solutions received official approval from the Moroccan health authorities to carry out its clinical trial in Morocco. This achievement allows the inclusion of the Hôpital d’Enfants de Rabat, a reference pediatric hospital in the country, in the efficacy phase of the study.

Newborn Solutions is one of 27 partners from 7 countries of the European research project “Listen2Future”. Our participation will allow us to incorporate highly integrated and cost-effective MEMS technologies to our solutions.

Together with ISGlobal we have access to a grant funded by the Bill & Melinda Gates Foundation to investigate how to improve meningitis suspicion, screening, and diagnostic accuracy in infants younger than 24 months and with permeable fontanel in hospitals and peripheral health centers in low and middle-income countries.

We will be exhibiting at MEDICA 2022 trade fair in Düsseldorf, Germany November 14th to 17th. We warmly welcome you to visit our booth in Hall 9, booth number B16. Javier Jimenez will also will be a speaker at the Connected Healthcare Forum in the MEDICA DISRUPT Session : Pushing the frontiers of diagnostics, on Thursday November 17th. We are looking forward to exchange about our technology and vision for the future.

We are thrilled to announce that we have been successfully selected as one of 74 European high potential startups for the 2022 EIC Accelerator’s first cut-off. The European Innovation Council (EIC) is Europe’s flagship innovation programme to identify, develop and scale up breakthrough technologies and game changing innovations. The EIC Accelerator’s selection is a challenging and highly selective process.